After 2017 (group 2)

Before 2017 (group 1)

Total

p-value

N = 15

N = 32

N = 47

AGE

10.9 ± 4.93

9.59 ± 5.06

10.0 ± 5.01

0.397

M n (%)

11 (73.3%)

22 (68.8%)

33 (70.2%)

Referral health facility

Tertiary hospital

7 (46.7%)

3

10

0.001

Secondary hospital

5 (33.3%)

28

33

Private practice

F n (%)

3 (0.2%)

4 (26.7%)

1

10 (31.2%)

4

14 (29.8%)

1.000

LAL

10 (6.67%)

28 (21.9%)

8 (17.0%)

0.065

LAM

5 (6.67%)

0 (0.00%)

1 (2.13%)

Time since diagnosis (month)

2.45 ± 2.87

4.88 ± 4.74

4.10 ± 4.36

0.036

Karnosky score:

0.002

40 - 50

0 (0.00%)

11 (34.26%)

9 (19.1%)

70

15 (100%)

12 (37.5%)

27 (57.4%)

80 - 100

0 (0.00%)

9 (11.25%)

2 (4.26%)

WBC (G/L) Moy ± sd

57.5 ± 51.2

76.2 ± 77.5

70.3 ± 70.2

0.331

Hb (G/L)

7.34 ± 2.22

3.31.0 ± 1.41

5.11.0 ± 3.21

Platelet (G/L)

78.9 ± 22.5

71.5 ± 43.5

74.7 ± 33.5

Follow up in month

5.92 ± 4.79

5.65 ± 11.6

5.74 ± 9.91

0.910